Patent details

EP2681220 Title: NOVEL CRYSTALLINE FORM OF A DPP-IV INHIBITOR

Basic Information

Publication number:
EP2681220
PCT Application Number:
PCT/IN/2012/000148
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127663292
PCT Publication Number:
WO/2012/147092
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL CRYSTALLINE FORM OF A DPP-IV INHIBITOR
French Title of Invention:
NOUVELLE FORME CRISTALLINE D'UN INHIBITEUR DE LA DPP-IV
German Title of Invention:
NEUARTIGE KRISTALLINE FORM EINES DPP-IV-HEMMERS
SPC Number:

Dates

Filing date:
02/03/2012
Grant date:
19/08/2015
EP Publication Date:
19/08/2015
PCT Publication Date:
01/11/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/01/2014
EP B1 Publication Date:
19/08/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2016
Expiration date:
02/03/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2012
 
 

Name:
Cadila Healthcare Limited
Address:
Zydus Tower Satellite Cross Roads, Ahmedabad 380 015, Gujarat, India (IN)

Inventor

1

Name:
DAVE Mayank Ghanshyambhai
Address:
India (IN)

2

Name:
SHUKLA Bhavin Shriprasad
Address:
India (IN)

3

Name:
KOTHARI Himanshu M.
Address:
India (IN)

4

Name:
PANDEY Bipin
Address:
India (IN)

Priority

1

Priority Number:
MM05902011
Priority Date:
03/03/2011
Priority Country:
India (IN)

2

Priority Number:
MM19482011
Priority Date:
06/07/2011
Priority Country:
India (IN)

3

Priority Number:
MM27772011
Priority Date:
30/09/2011
Priority Country:
India (IN)

Classification

Main IPC Class:
A61K 31/4985;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages